LauraJeanJohnstonMD

Hematology • Stanford, CA

Hematologic Oncology

Associate Professor, Medicine - Blood & Marrow Transplantation, Stanford University Medical Center

Join to view full profile

Dr. Johnston is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Johnston's full profile

Already have an account?

Office
300 Pasteur Dr
MC 5623
Stanford, CA 94305
Phone+1 650-723-0822

Fax+1 650-725-8950
Is this information wrong?

Education & Training

University of California (San Francisco)/FresnoFellowship, Hematology and Medical Oncology, 1995
University of California (San Francisco)Internship, Internal Medicine, 1989 - 1990
University of Minnesota Medical SchoolClass of 1989

Certifications & Licensure

CA State Medical License 1990 - 2024

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012

Clinical Trials

Peripheral Blood Stem Cell Transplant vs Bone Marrow Transplant in Individuals With Hematologic Cancers (BMT CTN 0201) Start of enrollment: 2004 Jan 01
Completed
Phase 3
Bone Marrow Grafting for Leukemia and Lymphoma Start of enrollment: 1988 Mar 01
Enrolling by invitation
Treatment for Acute Graft-Versus-Host Disease (BMT CTN 0302) Start of enrollment: 2005 Sep 01
Completed
Phase 2
Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD) (BMT CTN 0402) Start of enrollment: 2006 Nov 01
Completed
Phase 3
Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's Lymphoma Start of enrollment: 2007 Jan 01
Terminated
Phase 2
Nilotinib and Imatinib Mesylate After Donor Stem Cell Transplant in Treating Patients With ALL or CML Start of enrollment: 2008 Aug 14
Completed
Phase 1, Phase 2
Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder Start of enrollment: 2008 Oct 01
Completed
Phase 3
Chronic Graft-versus-Host Disease Treatment (BMT CTN 0801) Start of enrollment: 2010 Apr 01
Completed
Phase 2, Phase 3
Intravenous Administration of RGI-2001 in Patient Undergoing Allogenic Hematopoietic Stem Cell Transplantation (AHSCT) Start of enrollment: 2011 Sep 01
Completed
Phase 1, Phase 2
Post T-plant Infusion of Allogeneic Cytokine Induced Killer (CIK) Cells as Consolidative Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders Start of enrollment: 2011 Mar 01
Completed
Phase 2
Phase 1-2 MAHCT w/ TCell Depleted Graft w/ Simultaneous Infusion Conventional and Regulatory T Cell Start of enrollment: 2011 Dec 01
Completed
Phase 1, Phase 2
Phase 1 Infused Donor T Regulatory Cells in Steroid Dependent/Refractory Chronic GVHD Start of enrollment: 2013 Jul 01
Completed
Phase 1
Identifying Best Approach in Improving Quality of Life and Survival After a Donor Stem Cell Transplant in Older, Medically Infirm, or Frail Patients With Blood Diseases Start of enrollment: 2019 Aug 15
Recruiting
Phase 2, Phase 3
Join now to see all

Publications & Presentations

PubMed

21 citations
Concordance of peripheral blood and bone marrow measurable residual disease in adult acute lymphoblastic leukemia.
, , , , , , , , , , , , , , , , , , , > ;Blood Advances. 2021 Aug 24
NUTRITIONAL DEFICIENCY CONTRIBUTING TO REFRACTORY ERYTHRODERMA IN HEMATOPOETIC CELL TRANSPLANT PATIENTS: DISTINCTIVE CLINICAL AND HISTOPATHOLOGICAL FINDINGS
Mårten C.G. Winge, Kerri E. Rieger, Jinah Kim, Wen-Kai Weng, Laura Johnston, David B. Miklos, Lisa C. Zaba, Silvina Pugliese, Roberto A. Novoa, Bernice Y. Kwong> ;Journal of the American Academy of Dermatology. 2021 Aug 25
5 citations
Stem Cell Mobilization in Multiple Myeloma: Comparing Safety and Efficacy of Cyclophosphamide +/- Plerixafor versus Granulocyte Colony-Stimulating Factor +/- Plerixafo...
Andrew Johnsrud, Abdullah Ladha, Lori Muffly, Parveen Shiraz, Gary Goldstein, Victoria Osgood, Judith A. Shizuru, Laura Johnston, Sally Arai, Wen-Kai Weng, Robert Lows...> ;Transplantation and Cellular Therapy. 2021 Jul 1
8 citations
Outcomes after delayed and second autologous stem cell transplant in patients with relapsed multiple myeloma.
Christopher Lemieux, Lori Muffly, David J. Iberri, Juliana Craig, Laura Johnston, Robert Lowsky, Parveen Shiraz, Andrew R. Rezvani, Matthew J. Frank, Wen-Kai Weng, Eve...> ;Bone Marrow Transplantation. 2021 Jun 23
49 citations
CD22-directed CAR T-cell therapy induces complete remissions in CD19-directed CAR–refractory large B-cell lymphoma
Rezvani, A. R., John H. Baird, Matthew J. Frank, Juliana Craig, Shabnum Patel, Jay Y. Spiegel, Bita Sahaf, Jean Oak, Sheren F. Younes, Michael G. Ozawa, Eric H. Yang, ...> ;Blood. 2021 Apr 29
3 citations
Use of Backup Stem Cells for Stem Cell Boost and Second Transplant in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation
Emily C. Liang, Lori Muffly, Parveen Shiraz, Judith A. Shizuru, Laura Johnston, Sally Arai, Matthew J. Frank, Wen-Kai Weng, Robert Lowsky, Andrew R. Rezvani, Everett M...> ;Transplantation and Cellular Therapy. 2021 Feb 25
15 citations
Nonmyeloablative allogeneic transplantation achieves clinical and molecular remission in cutaneous T-cell lymphoma.
Wen-Kai Weng, Sally Arai, Andrew R. Rezvani, Laura Johnston, Robert Lowsky, David B. Miklos, Judith A. Shizuru, Lori Muffly, Everett Meyer, Robert S. Negrin, Erica Wan...> ;Blood Advances. 2020 Sep 22
8 citations
Outcomes with Autologous or Allogeneic Stem Cell Transplantation in Patients with Plasma Cell Leukemia in the Era of Novel Agents
Christopher Lemieux, Laura Johnston, Robert Lowsky, Lori Muffly, Juliana Craig, Parveen Shiraz, Andrew R. Rezvani, Matthew J. Frank, Wen-Kai Weng, Everett Meyer, Judit...> ;Biology of Blood and Marrow Transplantation. 2020 Dec 1
6 citations
Outcomes with autologous stem cell transplant vs. non-transplant therapy in patients 70 years and older with multiple myeloma
Christopher Lemieux, Lori Muffly, Andrew R. Rezvani, Robert Lowsky, David J. Iberri, Juliana Craig, Matthew J. Frank, Laura Johnston, Michaela Liedtke, Robert S. Negri...> ;Bone Marrow Transplantation. 2021 Feb 1
11 citations
Machine Learning Algorithms to Differentiate Among Pulmonary Complications After Hematopoietic Cell Transplant
Husham Sharifi, Yu Kuang Lai, Henry Guo, Mita Shah Hoppenfeld, Zachary D. Guenther, Laura Johnston, Theresa Brondstetter, Laveena Chhatwani, Mark R. Nicolls, Joe L. Hsu> ;Chest. 2020 Sep 1
61 citations
Hematopoietic Cell Transplantation in the Treatment of Adult Acute Lymphoblastic Leukemia: Updated 2019 Evidence-Based Review from the American Society for Transplanta...
Zachariah DeFilipp, Anjali S. Advani, Veronika Bachanova, Ryan D. Cassaday, Daniel J. DeAngelo, Partow Kebriaei, Jacob M. Rowe, Matthew D. Seftel, Wendy Stock, Martin ...> ;Biology of Blood and Marrow Transplantation. 2019 Nov 1
84 citations
Clinical utilization of Chimeric Antigen Receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL)–an expert opinion from the European Society for Blood an...
Ankit Kansagra, Noelle V. Frey, Merav Bar, Theodore W. Laetsch, Paul A. Carpenter, Bipin N. Savani, Helen E. Heslop, Catherine M. Bollard, Krishna V. Komanduri, Dennis...> ;Bone Marrow Transplantation. 2019 Nov 1
12 citations
Nonmyeloablative TLI-ATG conditioning for allogeneic transplantation: mature follow-up from a large single-center cohort
Michael A. Spinner, Vanessa E Kennedy, John S. Tamaresis, Philip W. Lavori, Sally Arai, Laura Johnston, Everett Meyer, David B. Miklos, Lori Muffly, Robert S. Negrin, ...> ;Blood Advances. 2019 Aug 27
37 citations
Transplantation of donor grafts with defined ratio of conventional and regulatory T cells in HLA-matched recipients
Everett Meyer, Ginna G. Laport, Bryan J. Xie, Kate MacDonald, Kartoosh Heydari, Bita Sahaf, Sai-Wen Tang, Jeanette Baker, Randall Armstrong, Keri Tate, Cynthia Tadisco...> ;JCI Insight. 2019 May 16
90 citations
Clinical Utilization of Chimeric Antigen Receptor T Cells in B Cell Acute Lymphoblastic Leukemia: An Expert Opinion from the European Society for Blood and Marrow Tran...
Ankit Kansagra, Noelle V. Frey, Merav Bar, Theodore W. Laetsch, Paul A. Carpenter, Bipin N. Savani, Helen E. Heslop, Catherine M. Bollard, Krishna V. Komanduri, Dennis...> ;Biology of Blood and Marrow Transplantation. 2019 Mar 1
4 citations
ASBMT Statement on Routine Prophylaxis for Central Nervous System Recurrence of Acute Lymphoblastic Leukemia following Allogeneic Hematopoietic Cell Transplantation
Craig S. Sauter, Zachariah DeFilipp, Yoshihiro Inamoto, Laura Johnston, Arnon Nagler, Bipin N. Savani, Paul A. Carpenter, Miguel-Angel Perales> ;Biology of Blood and Marrow Transplantation. 2019 Mar 1
28 citations
A phase II/III randomized, multicenter trial of prednisone/sirolimus versus prednisone/ sirolimus/calcineurin inhibitor for the treatment of chronic graft-versus-host ...
Paul A. Carpenter, Brent R. Logan, Stephanie J. Lee, Daniel J. Weisdorf, Laura Johnston, Luciano J. Costa, Carrie L. Kitko, Javier Bolaños-Meade, Stefanie Sarantopoulo...> ;Haematologica. 2018 Nov 1
Minimal floor space allowance for gestating sows kept in pens with electronic sow feeders on fully-slatted floors.
Li, Y. Z.,Cui, S. Q.,Yang, X. J.,Johnston, L. J.,Baidoo, S. K.> ;J. Anim. Sci.. 2018 Jul 23
26 citations
Infusion of donor-derived CD8+ memory T cells for relapse following allogeneic hematopoietic cell transplantation.
Lori Muffly, Kevin Sheehan, Randall Armstrong, Kent P. Jensen, Keri Tate, Andrew R. Rezvani, David B. Miklos, Sally Arai, Judith A. Shizuru, Laura Johnston, Everett Me...> ;Blood Advances. 2018 Mar 27
3 citations
Heart Rate Variability Markers as Correlates of Survival in Recipients of Hematopoietic Cell Transplantation
Caroline Scheiber, Laura Johnston, Mary Melissa Packer, Richard Gevirtz, Katharine S. Edwards, Oxana Palesh> ;Oncology Nursing Forum. 2018 Mar 1
Anti-Platelet-Derived Growth Factor Receptor Alpha Chain Antibodies Predict for Response to Nilotinib in Steroid-Refractory or -Dependent Chronic Graft-Versus-Host Dis...
Chen, G. L.,Carpenter, P. A.,Broady, R.,Gregory, T. K.,Johnston, L. J.,Storer, B. E.,Beumer, J. H.,Qiu, J.,Cerda, K.,Le, R.,Otani, J. M.,Liu, H.,Ross, M. A.,Arai, S.,F...> ;Biol. Blood Marrow Transplant.. 2017 Oct 21
Effectiveness of different corn dried distillers grains with solubles feeding strategies and increasing the time intervals between the second Improvest dose and slaugh...
Harris, E. K.,Mellencamp, M. A.,Johnston, L. J.,Cox, R. B.,Shurson, G. C.> ;Meat Sci.. 2017 Sep 20
Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti–T-lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease–Free Survival in Pa...
Usama Gergis, Peter Westervelt, Robert J Soiffer, Madan H Jagasia, John F DiPersio, Patrick J Stiff, Vincent T Ho, Joseph McGuirk, Laura Johnston, Andrew Artz, Ran Res...> ;Journal of Clinical Oncology. 2017 Oct 19
10 citations
Validation of the Hematopoietic Cell Transplantation–Specific Comorbidity Index in Nonmyeloablative Allogeneic Stem Cell Transplantation
Muthu Veeraputhiran, Lingyao Yang, Vandana Sundaram, Sally Arai, Robert Lowsky, David B. Miklos, Everett Meyer, Lori Muffly, Robert S. Negrin, Andrew R. Rezvani, Judit...> ;Biology of Blood and Marrow Transplantation. 2017 Oct 1
8 citations
HLA-mismatched unrelated donor transplantation using TLI-ATG conditioning has a low risk of GVHD and potent antitumor activity.
Michael A. Spinner, Marcelo Fernandez-Vina, Lisa E. Creary, Olivia Quinn, Linda Elder, Sally Arai, Laura Johnston, Everett Meyer, David B. Miklos, Lori Muffly, Robert ...> ;Blood Advances. 2017 Jul 25
Join now to see all

Abstracts/Posters

Improved Outcomes for Relapsed/Refractory Classic Hodgkin Lymphoma Following Autologous Stem Cell Transplantation in the Era of Novel Agents
Laura J Johnston, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019